Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.56Price to Book
VS
Market
Sector
Industry
History
$ 2.41Close
$ 2 - $ 2.7 52-Week Range
Ticker Information
Ticker
ORMPCompany Name
ORAMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQORAMED PHARMACEUTICALS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ORMP - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 154.53M | $ 86.93M | 0.56 |
| 3/31/2025 | $ 140.81M | $ 89.87M | 0.64 |
| 12/31/2024 | $ 146.26M | $ 93.96M | 0.64 |
| 9/30/2024 | $ 156.44M | $ 95.94M | 0.61 |
| 6/30/2024 | $ 177.06M | $ 91.32M | 0.52 |
| 3/31/2024 | $ 166.64M | $ 96.7M | 0.58 |
| 12/31/2023 | $ 163.82M | $ 116.29M | 0.71 |
| 9/30/2023 | $ 149.13M | $ 78.66M | 0.53 |
| 6/30/2023 | $ 151.55M | $ 128.48M | 0.85 |
| 3/31/2023 | $ 150.97M | $ 112.88M | 0.75 |
Key Performance Insights, Last 5 Years
- ORAMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/B stands at 2.
- Over the past 5 years, ORAMED PHARMACEUTICALS INC's average P/B has been 1.96.
- The median P/B for ORAMED PHARMACEUTICALS INC during this period was 0.8
- ORAMED PHARMACEUTICALS INC reached its highest P/B over the past 5 years at 6.54.
- The lowest P/B recorded by ORAMED PHARMACEUTICALS INC in the same timeframe 0.52
ORAMED PHARMACEUTICALS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for ORAMED PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 65.82M ] / Equity [ $ 32.88M ]
(=) P/B [ 2 ] ORMP - Price to Book, Last 5 years
0.52
Minimum
Jun 30, 2024
6.54
Maximum
Jun 30, 2021
1.96
Average
0.8
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |